Concepedia
Statistics
Publications
51
Citations
3.1K
H-Index
30
Active since
1971
Affiliations
AstraZeneca (United Kingdom)(Current)
MRC Toxicology Unit
Brunel University of London
Syngenta (United Kingdom)
P.A. Lefevre is an author at AstraZeneca (United Kingdom) specializing in toxicology, pharmacy, and carcinogenic mechanisms.
Publications per year
1971–2004
An evaluation of 6 short-term tests for detecting organic chemical carcinogens
I. F. H. Purchase, E. Longstaff, J. Ashby et al. · British Journal of Cancer · 1978 · 426 citations
Pharmacy, Clinical Toxicology, Toxicology +9
The Rodent Uterotrophic Assay: Critical Protocol Features, Studies with Nonyl Phenols, and Comparison with a Yeast Estrogenicity Assay
J. Odum, P.A. Lefevre, S. Tittensor et al. · Regulatory Toxicology and Pharmacology · 1997 · 278 citations
Medicine, Biochemistry, Endocrinology +12
Evaluation of six short term tests for detecting organic chemical carcinogens and recommendations for their use
I. F. H. Purchase, E. Longstaff, John Ashby et al. · Nature · 1976 · 277 citations
Pharmacy, Clinical Toxicology, Toxicology +8
Direct observation of substance P-induced internalization of neurokinin 1 (NK1) receptors at sites of inflammation.
Jeffrey J. Bowden, Adella Garland, P.A. Lefevre et al. · Proceedings of the National Academy of Sciences · 1994 · 255 citations
Life Sciences, Cell Biology, Pharmacology +15
The single cell gel electrophoresis assay for induced DNA damage (comet assay): measurement of tail length and moment
J. Ashby, H. Tinwell, P.A. Lefevre et al. · Mutagenesis · 1995 · 172 citations
Pharmacy, Cell Biology, Toxicology +17
1–5 of 51